Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

Smithfield Foods, Inc.

SFD
Consumer Staples · Packaged Foods

Smithfield Foods, Inc. is printing record margins on a fuller multiple. From here the earnings must do all the lifting.

Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding.

The price is in a confirmed uptrend (9 weeks in) while the P/E sits at the 56th percentile of its own 2-year range. Underneath, the last four quarters read improving — profit +8.7% year on year, and 109% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.

Stage
Mixed
fundamental trajectory, 12 quarters
Price
$25.3
+4.2% 1Y
P/E
9.9×
56th pctile
of its own 2-year range
Revenue (Mar 26)
$3.8 B
+0.8% YoY
Profit (Mar 26)
$0.3 B
+8.7% YoY
Operating margin
8.7%
+0.2 pp YoY
ROE
15%
FY25
ROIC
13.1%
Cash conversion
109%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Smithfield Foods, Inc. trades at $25.3, in a confirmed uptrend and 9 weeks into that stage. That is +3.4% against its own 200-day average. It sits at 51% of a 52-week range of $21 to $29. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (8 weeks and counting).

Today the stock is in a confirmed uptrend — week 9 of stage 2. At $25.3 it trades +3.4% versus its 200-day average and sits at 51% of its 52-week range ($21–$29).

Aug 26: $25.3 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 2-year window.
+3.4% versus the 200-day line, week 9 of stage 2
Price50-day avg200-day avg
S2$30.2$27.2$24.2$21.2$18.2$$25$25Jan 25Jun 25Oct 25Mar 26Aug 26
S2$30.2$27.2$24.2$21.2$18.2$$25$25Jan 25Oct 25Aug 26
Beating or trailing, week by week since 2025 Each cell is one week from 2025 to now (80 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jan 25Aug 26

Against the market, two honest reads. Cumulative: over the last 1.5 years the stock moved +18% while the S&P 500 moved +28% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (8 weeks and counting; last ahead the week of 2026-06-12) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Smithfield Foods, Inc. trades at 9.9× P/E, mid-range by its own standards (56th percentile). Its long-run median P/E is 9.8×, measured across 1.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 9.9× is mid-range by its own standards (56th percentile), against a long-run median of 9.8× measured over 1.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 9.9× vs a 9.8× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 1.5-year window; loss-period spikes above 11× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
mid-range by its own standards (56th percentile)
P/EMedianEPS (TTM) (quarterly)
11.7×$2.910.6×$2.29.4×$1.48.2×$0.77.1×$0.0×$9.90×$3Jan 25Jun 25Oct 25Mar 26Aug 26
11.7×$2.910.6×$2.29.4×$1.48.2×$0.77.1×$0.0×$9.90×$3Jan 25Oct 25Aug 26
PEG 10.94 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 5 quarters; values above 6 pinned at the top.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
6.4×4.9×3.5×2.0×0.6××6.00×Mar 25Jun 25Sep 25Dec 25Mar 26
6.4×4.9×3.5×2.0×0.6××6.00×Mar 25Sep 25Mar 26
P/E
9.9×
56th percentile of 2y
PEG
18.36
as reported

Why the multiple sits where it does: over the past year annual EPS moved +0.0% against a +4.2% price move — the price outran earnings, pushing the multiple UP its own range.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Smithfield Foods, Inc. reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 12.9% — the per-curve reads carry the story. The read is built from 10 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +9.8% in FY25, profit +25.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
11%327%6.5%230%1.9%133%−2.6%37%−7.2%−60%%%9.8%25%FY13FY14FY25
11%327%6.5%230%1.9%133%−2.6%37%−7.2%−60%%%9.8%25%FY13FY14FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit rolling over
RevenueProfitEPS
11%330%7.5%222%4.0%115%0.6%7.3%−2.9%−100%%%7.7%10.9%−4.1%Oct 16Sep 24Mar 26
11%330%7.5%222%4.0%115%0.6%7.3%−2.9%−100%%%7.7%10.9%−4.1%Oct 16Sep 24Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
14%11%8.6%6.0%3.5%%12.9%Oct 16Dec 23Sep 24Jun 25Mar 26
14%11%8.6%6.0%3.5%%12.9%Oct 16Sep 24Mar 26
Revenue growth
Steady high
latest +7.7% · span −1.9% to +10.0%
Profit growth
Rolling over
latest +10.9% · span −70.5% to +607.7%
EPS growth
Falling
latest −4.1% · span −52.4% to +356.7%
ROCE
Stuck low
latest 12.9% · span 4.2%–13.0%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+9.8%
Profit+25.0%
EPS+0.0%
Stock price+4.2%
Revenue YoY (Mar 26)
+0.8%
latest quarter vs a year ago
Profit YoY (Mar 26)
+8.7%
latest quarter vs a year ago
Revenue 10y
1.4%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

51.3/100 — rank 8 of 30 in Packaged Foods · 66% evidence confidence

Smithfield Foods, Inc. scores 51.3 out of 100 against the 30 companies it is compared with in Packaged Foods, ranking 8. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 17.4 + 13.4 + 13.5 + 7 = 51.3. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Smithfield Foods, Inc. reported $3.8 B of revenue in the Mar 26 quarter, +0.8% year on year. That is the 5th straight quarter of year-on-year growth. Over 12 years it has compounded at 1.4% a year. The last full year, FY25, came in at $15.5 B. The last four reported quarters add to $15.6 B.

FY25 revenue came in at $15.5 B (+9.8% on the year), capping 12 years at 1.4% compound. The latest quarter (Mar 26) printed $3.8 B, +0.8% year on year — the 5th consecutive quarter of year-over-year growth.

FY25 revenue $15.5 B (+9.8% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
1.4% a year over 12 years
RevenueYoY growth
1711%136.5%8.41.9%4.2−2.6%0.0−7.2%$ B%$16B9.8%FY13FY14FY25
1711%136.5%8.41.9%4.2−2.6%0.0−7.2%$ B%$16B9.8%FY13FY14FY25
Mar 26: $3.8 B (+0.8% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
5th straight quarter of growth
Revenue (quarterly)YoY growth
4.614%3.49.6%2.35.5%1.11.5%0.0−2.6%$ B%$4B0.8%Oct 16Sep 24Mar 26
4.614%3.49.6%2.35.5%1.11.5%0.0−2.6%$ B%$4B0.8%Oct 16Sep 24Mar 26

Pace check: the last four quarters averaged +7.9% growth against the decade's 1.4% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +7.7% over the last 4 quarters against +4.1%/yr over the last 8 — accelerating; TTM profit +10.9% vs +180.1%/yr — rolling over.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Smithfield Foods, Inc.'s operating margin is 8.7% in the Mar 26 quarter, +0.2 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged 2.4% to 8.3%. The current quarter is running above every full year in that window.

The latest quarter's operating margin is 8.7%, +0.2 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 2.4%–8.3%, and FY25's 8.3% is the top of that band — a record year.

Why the margin moved: operating margin went +0.2 pp year on year while gross margin went −0.1 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

FY25: 8.3% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
the widest a 2.4–8.3% band over 5 years
operating marginYoY change (pp)
8.8%4.2%7.1%2.7%5.3%1.2%3.6%−0.4%1.9%−1.9%%%8.3%0.4%FY13FY14FY25
8.8%4.2%7.1%2.7%5.3%1.2%3.6%−0.4%1.9%−1.9%%%8.3%0.4%FY13FY14FY25
Mar 26: 8.7% operating margin (+0.2 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
11%13%7.0%8.6%3.3%4.4%−0.3%0.2%−4.0%−4.0%%%8.7%0.2%Oct 16Sep 24Mar 26
11%13%7.0%8.6%3.3%4.4%−0.3%0.2%−4.0%−4.0%%%8.7%0.2%Oct 16Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Smithfield Foods, Inc. earned $0.3 B of net profit in the Mar 26 quarter, +8.7% year on year. It is the 3rd consecutive quarter of growth. Full-year FY25 profit was $1.0 B. The 12-year compound rate is 15.4%. That is 6.6% of the quarter's revenue. The same quarter a year earlier earned $0.2 B.

Mar 26 profit was $0.3 B, +8.7% year on year — the 3rd consecutive quarter of growth. On the full year, FY25 printed $1.0 B (+25.0%), and the 12-year compound rate is 15.4%.

FY25 profit $1.0 B (+25.0% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
15.4% a year over 12 years
Net profitYoY growth
1.1399%0.8283%0.5167%0.351%0.0−65%$ B%$1B25%FY13FY14FY25
1.1399%0.8283%0.5167%0.351%0.0−65%$ B%$1B25%FY13FY14FY25
Mar 26: $0.3 B (+8.7% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
3rd straight quarter of growth
Net profit (quarterly)YoY growth
0.42,162%0.21,574%0.1987%0.0399%−0.2−189%$ B%$0B8.7%Oct 16Sep 24Mar 26
0.42,162%0.21,574%0.1987%0.0399%−0.2−189%$ B%$0B8.7%Oct 16Sep 24Mar 26

Why profit moved: revenue contributed +0.8% and the margin +0.2 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +12.7% vs revenue +7.9%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 109% of Smithfield Foods, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $1.1 B of operating cash against $1.0 B of profit. After $0.3 B of capital spending, $0.7 B was left as free cash.

FY25: operating cash of $1.1 B against reported profit of $1.0 B, leaving free cash of $0.7 B after $0.3 B of capital spending. Across the last 3 fiscal years the conversion rate is 109% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $1.1 B vs profit $1.0 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 3-year window, annual resolution.
109% of 3-year profit arrived as cash
Operating cashNet profitFree cash
1.20.80.50.1−0.2$ B$1B$1B$1BFY13FY24FY25
1.20.80.50.1−0.2$ B$1B$1B$1BFY13FY24FY25
Dec 25: operating cash $0.9 B = 285% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 11 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
1.0355%0.7188%0.321%−0.1−146%−0.4−313%$ B%$1B285%Mar 15Mar 24Dec 25
1.0355%0.7188%0.321%−0.1−146%−0.4−313%$ B%$1B285%Mar 15Mar 24Dec 25

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Smithfield Foods, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 2.1% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $1.0 B over the last 3 fiscal years.

FY25: capex $0.3 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.40.30.20.10.0$ B$0BFY13FY24FY25
0.40.30.20.10.0$ B$0BFY13FY24FY25
Dec 25: capex $0.1 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 11 quarters.
Capex (quarterly)Free cash
0.110.90.080.60.050.20.03−0.10.00−0.5$ B$ B$0B$1BMar 15Mar 24Dec 25
0.110.90.080.60.050.20.03−0.10.00−0.5$ B$ B$0B$1BMar 15Mar 24Dec 25

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Smithfield Foods, Inc. earns a ROE of 14% in FY25. That is up from a trough of 3% in FY13. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 6.4% net margin on 1.28× asset turns.

FY25 ROE is 14%, recovered from a FY13 trough of 3% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY25): 6.4% net margin × 1.28× asset turns × 1.73× balance-sheet leverage ≈ 14.2% on equity. Margin does its share; leverage is a meaningful part of the equation.

FY25: ROE 14% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included.
the climb back from FY13's 3%
ROEROIC (annual)
15%12%8.5%5.2%1.9%%14.2%13.1%FY13FY14FY25
15%12%8.5%5.2%1.9%%14.2%13.1%FY13FY14FY25
Mar 26: ROIC 12.4% (TTM) Trailing-twelve-month ROIC and ROE, per quarter, %. Last 10 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)
25%19%13%7.4%1.7%%12.4%18.4%Oct 16Dec 24Mar 26
25%19%13%7.4%1.7%%12.4%18.4%Oct 16Dec 24Mar 26
11 · Dividend

Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.

Smithfield Foods, Inc. paid $1.06 per share over the last four reported quarters, up 25.0% on a year ago. The most recent declaration was $0.31 for Mar 26. Against the current price of $25.3 that is a trailing yield of 4.18%, measured on dividends already paid rather than on a forecast.

Smithfield Foods, Inc. paid $1.06 per share across the last four reported quarters, most recently $0.31 for Mar 26. That is up 25.0% against the same quarter a year earlier. Against the current price of $25.3 the trailing twelve months work out to 4.18% — trailing dividends measured against today's price, not a forward estimate.

Dividend per share by quarter Declared dividend per share, $ B, per reported quarter. 5 quarters on file.
latest $0.31 (Mar 26)
Dividend per share
0.340.250.170.080.00$ B$0BMar 25Jun 25Sep 25Dec 25Mar 26
0.340.250.170.080.00$ B$0BMar 25Sep 25Mar 26
12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Smithfield Foods, Inc. carries total debt of $1.7 B against shareholder equity of $7.2 B as of Mar 26, a debt-to-equity of 0.24 — effectively unlevered. On the annual view that ratio went from 0.81 in FY13 to 0.34 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of $1.7 B against shareholder equity of $7.2 B — a debt-to-equity of 0.24. On the annual view, debt-to-equity went from 0.81 (FY13) to 0.34 (FY25). The returns on this page are earned, not borrowed.

FY25: debt $2.4 B at 0.34× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
3.30.8×2.50.7×1.60.6×0.80.4×0.00.3×$ B×$2B0.34×FY13FY14FY25
3.30.8×2.50.7×1.60.6×0.80.4×0.00.3×$ B×$2B0.34×FY13FY14FY25
Mar 26: debt $1.7 B, debt-to-equity 0.24 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
2.70.50×2.00.43×1.30.36×0.70.29×0.00.22×$ B×$2B0.24×Apr 16Sep 24Mar 26
2.70.50×2.00.43×1.30.36×0.70.29×0.00.22×$ B×$2B0.24×Apr 16Sep 24Mar 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

12.6% of Smithfield Foods, Inc.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 4.1 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 12.6% of the float is sold short, and at typical trading volumes it would take about 4.1 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
12.6%
of the tradable float
Days to cover
4.1
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Smithfield Foods, Inc.: the Z-score reads 3.55. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 3.55 sits well clear of the distress zone — the balance sheet is not the risk here.

The safety line in one sentence: the Z-score reads 3.55.

15 · Related companies · Packaged Foods
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Seneca Foods CorporationSENEA 65.4/100Thin evidence · provisional60% evidence TURNING 22.9/35 Revenue 5.1% · PAT 100% · OPM change 5.4 pp 53% evidence 10.8/25 ROCE 2.3% · OPM 6% 57% evidence 15.7/20 P/E 9.1× · PEG 0.28 65% evidence 16.0/20 RS sector 25.6% · RS bench 18.5% · 1Y 69%5 of 12 weeks ahead 70% evidence
Exact sum: 22.9 + 10.8 + 15.7 + 16 = 65.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
2Darling Ingredients Inc.DAR 62.8/100Thin evidence · provisional56% evidence ASLEEP 23.2/35 Revenue — · PAT — · OPM change 9.5 pp 39% evidence 17.1/25 ROCE 12% · OPM 14.6% 76% evidence 9.8/20 P/E 15.2× · PEG — 15% evidence 12.7/20 RS sector 22.3% · RS bench 16.1% · 1Y 96.4%1 of 12 weeks ahead 100% evidence
Exact sum: 23.2 + 17.1 + 9.8 + 12.7 = 62.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
3Central Garden & Pet CompanyCENT 62.5/100Mixed-positive evidence66% evidence BREAKING OUT 19.7/35 Revenue 0.2% · PAT 37.9% · OPM change 0.8 pp 53% evidence 13.6/25 ROCE 8.8% · OPM 12.6% 57% evidence 15.1/20 P/E 12.1× · PEG 0.25 65% evidence 14.1/20 RS sector 15.4% · RS bench 8.4% · 1Y 29.3%7 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 13.6 + 15.1 + 14.1 = 62.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Mama's Creations, Inc.MAMA 59.9/100Mixed-positive evidence81% evidence BREAKING OUT 24.5/35 Revenue 46.5% · PAT 50% · OPM change 0.5 pp 83% evidence 11.3/25 ROCE 5.3% · OPM 5% 76% evidence 5.6/20 P/E 94.6× · PEG 2.6 65% evidence 18.5/20 RS sector 30.7% · RS bench 23.5% · 1Y 135.2%8 of 12 weeks ahead 100% evidence
Exact sum: 24.5 + 11.3 + 5.6 + 18.5 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5The J. M. Smucker CompanySJM 59.7/100Mixed-positive evidence64% evidence BREAKING OUT 22.5/35 Revenue 3.7% · PAT — · OPM change 47.5 pp 62% evidence 12.9/25 ROCE 3.1% · OPM 19.6% 76% evidence 9.1/20 P/E 23× · PEG — 15% evidence 15.2/20 RS sector 7.9% · RS bench 0.9% · 1Y 7.6%7 of 12 weeks ahead 100% evidence
Exact sum: 22.5 + 12.9 + 9.1 + 15.2 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6John B. Sanfilippo & Son, Inc.JBSS 58.8/100Thin evidence · provisional60% evidence TURNING 16.6/35 Revenue 5.1% · PAT 21.4% · OPM change -2.4 pp 53% evidence 13.8/25 ROCE 5.2% · OPM 8.4% 57% evidence 13.9/20 P/E 13.6× · PEG 0.67 65% evidence 14.5/20 RS sector 8.5% · RS bench 2% · 1Y 34%0 of 12 weeks ahead 70% evidence
Exact sum: 16.6 + 13.8 + 13.9 + 14.5 = 58.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
7The Campbell's CompanyCPB 56.0/100Mixed-positive evidence81% evidence TURNING 22.1/35 Revenue -2.9% · PAT 33.9% · OPM change 3.6 pp 83% evidence 11.8/25 ROCE 2% · OPM 10.1% 76% evidence 15.2/20 P/E 10.3× · PEG 0.3 65% evidence 6.9/20 RS sector -16.8% · RS bench -23.1% · 1Y -29.8%0 of 12 weeks ahead 100% evidence
Exact sum: 22.1 + 11.8 + 15.2 + 6.9 = 56 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Smithfield Foods, Inc.this pageSFD 51.3/100Mixed-positive evidence66% evidence BASING 17.4/35 Revenue 7.5% · PAT 12.1% · OPM change 0.3 pp 53% evidence 13.4/25 ROCE 3.1% · OPM 8.8% 57% evidence 13.5/20 P/E 10.4× · PEG 0.96 65% evidence 7.0/20 RS sector -0.8% · RS bench -7% · 1Y -0.7%0 of 12 weeks ahead 100% evidence
Exact sum: 17.4 + 13.4 + 13.5 + 7 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9Lamb Weston Holdings, Inc.LW 50.6/100Thin evidence · provisional56% evidence TURNING 14.9/35 Revenue — · PAT — · OPM change -8.3 pp 39% evidence 12.0/25 ROCE 2.8% · OPM 8.1% 76% evidence 9.5/20 P/E 20.8× · PEG — 15% evidence 14.2/20 RS sector 2.4% · RS bench -4.8% · 1Y 3.2%3 of 12 weeks ahead 100% evidence
Exact sum: 14.9 + 12 + 9.5 + 14.2 = 50.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10Utz Brands, Inc.UTZ 50.4/100Thin evidence · provisional56% evidence TURNING 14.7/35 Revenue 2.3% · PAT -144.1% · OPM change 0.6 pp 53% evidence 7.3/25 ROCE 0.3% · OPM 2.2% 57% evidence 8.5/20 P/E 1046× · PEG — 15% evidence 19.9/20 RS sector 37.4% · RS bench 27% · 1Y 10.5%3 of 12 weeks ahead 100% evidence
Exact sum: 14.7 + 7.3 + 8.5 + 19.9 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11JBS N.V.JBS 47.6/100Thin evidence · provisional60% evidence BASING 15.5/35 Revenue 12.1% · PAT -11.3% · OPM change -2.3 pp 53% evidence 9.6/25 ROCE 1.5% · OPM 2.2% 57% evidence 15.5/20 P/E 11.3× · PEG 0.16 65% evidence 7.0/20 RS sector -9.9% · RS bench -16% · 1Y -4.8%0 of 12 weeks ahead 70% evidence
Exact sum: 15.5 + 9.6 + 15.5 + 7 = 47.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12The Kraft Heinz CompanyKHC 47.0/100Thin evidence · provisional56% evidence TURNING 13.4/35 Revenue -1.8% · PAT -317% · OPM change -1 pp 53% evidence 11.4/25 ROCE 1.5% · OPM 18.9% 57% evidence 9.9/20 P/E 13.8× · PEG — 15% evidence 12.3/20 RS sector 4.2% · RS bench -2.7% · 1Y -4%4 of 12 weeks ahead 100% evidence
Exact sum: 13.4 + 11.4 + 9.9 + 12.3 = 47 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
13Hormel Foods CorporationHRL 46.3/100Mixed-negative evidence71% evidence BREAKING OUT 13.1/35 Revenue 2.5% · PAT -37.6% · OPM change -1.3 pp 83% evidence 10.7/25 ROCE 1.8% · OPM 7.3% 76% evidence 8.9/20 P/E 25.4× · PEG — 15% evidence 13.6/20 RS sector 2% · RS bench -4.9% · 1Y -11%5 of 12 weeks ahead 100% evidence
Exact sum: 13.1 + 10.7 + 8.9 + 13.6 = 46.3 · Decision use: Price leads the evidence: RS versus the benchmark is -4.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
14Ingredion IncorporatedINGR 45.4/100Mixed-negative evidence66% evidence BASING 14.4/35 Revenue -2.2% · PAT 7.2% · OPM change -3.9 pp 53% evidence 14.0/25 ROCE 3.1% · OPM 11.3% 57% evidence 12.5/20 P/E 10.9× · PEG 1.14 65% evidence 4.5/20 RS sector -10.3% · RS bench -16.5% · 1Y -17.1%0 of 12 weeks ahead 100% evidence
Exact sum: 14.4 + 14 + 12.5 + 4.5 = 45.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15McCormick & Company, IncorporatedMKC 45.3/100Mixed-negative evidence81% evidence TURNING 18.4/35 Revenue 9.5% · PAT 1.1% · OPM change -0.5 pp 83% evidence 14.2/25 ROCE 2.4% · OPM 14.3% 76% evidence 6.7/20 P/E 7.9× · PEG 4.94 65% evidence 6.0/20 RS sector -16.9% · RS bench -23% · 1Y -26%0 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 14.2 + 6.7 + 6 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16BellRing Brands, Inc.BRBR 45.3/100Thin evidence · provisional60% evidence TURNING 13.0/35 Revenue 6.4% · PAT -43.6% · OPM change -5.2 pp 53% evidence 15.5/25 ROCE 9.2% · OPM 11% 57% evidence 13.8/20 P/E 12.5× · PEG 0.7 65% evidence 3.0/20 RS sector -45.3% · RS bench -50.3% · 1Y -67.3%1 of 12 weeks ahead 70% evidence
Exact sum: 13 + 15.5 + 13.8 + 3 = 45.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
17Freshpet, Inc.FRPT 45.1/100Mixed-negative evidence61% evidence TURNING 20.5/35 Revenue 12.1% · PAT 100% · OPM change 5.9 pp 40% evidence 6.9/25 ROCE 0.3% · OPM 1.5% 57% evidence 5.3/20 P/E 15.8× · PEG 2.98 65% evidence 12.4/20 RS sector 0% · RS bench -6.8% · 1Y -0.6%1 of 12 weeks ahead 100% evidence
Exact sum: 20.5 + 6.9 + 5.3 + 12.4 = 45.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Nomad Foods LimitedNOMD 43.7/100Thin evidence · provisional60% evidence BREAKING OUT 13.3/35 Revenue -2.9% · PAT -40.9% · OPM change -1.8 pp 53% evidence 10.3/25 ROCE 1.1% · OPM 7.9% 57% evidence 11.5/20 P/E 9.3× · PEG 1.49 65% evidence 8.6/20 RS sector -2.1% · RS bench -9.2% · 1Y -26.3%6 of 12 weeks ahead 70% evidence
Exact sum: 13.3 + 10.3 + 11.5 + 8.6 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
19The Marzetti CompanyMZTI 40.7/100Mixed-negative evidence66% evidence BASING 15.8/35 Revenue 2.8% · PAT 3.5% · OPM change -0.6 pp 53% evidence 13.4/25 ROCE 4.1% · OPM 10.3% 57% evidence 8.7/20 P/E 21.6× · PEG 1.71 65% evidence 2.8/20 RS sector -28.7% · RS bench -34.2% · 1Y -38.1%0 of 12 weeks ahead 100% evidence
Exact sum: 15.8 + 13.4 + 8.7 + 2.8 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Conagra Brands, Inc.CAG 39.8/100Thin evidence · provisional56% evidence TURNING 15.5/35 Revenue — · PAT — · OPM change 1.6 pp 39% evidence 6.8/25 ROCE -10.8% · OPM 10% 76% evidence 10.6/20 P/E 11.2× · PEG — 15% evidence 6.9/20 RS sector -13.1% · RS bench -19.4% · 1Y -22.1%0 of 12 weeks ahead 100% evidence
Exact sum: 15.5 + 6.8 + 10.6 + 6.9 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
21Post Holdings, Inc.POST 38.8/100Mixed-negative evidence66% evidence BASING 18.5/35 Revenue 7.2% · PAT -5% · OPM change 1.1 pp 53% evidence 11.6/25 ROCE 1.8% · OPM 10.4% 57% evidence 5.6/20 P/E 16.6× · PEG 2.92 65% evidence 3.1/20 RS sector -13.8% · RS bench -19.6% · 1Y -16.1%0 of 12 weeks ahead 100% evidence
Exact sum: 18.5 + 11.6 + 5.6 + 3.1 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Flowers Foods, Inc.FLO 38.3/100Thin evidence · provisional56% evidence ASLEEP 16.9/35 Revenue — · PAT — · OPM change -0.4 pp 39% evidence 10.1/25 ROCE 2.3% · OPM 5.1% 76% evidence 9.4/20 P/E 21.5× · PEG — 15% evidence 1.9/20 RS sector -31.3% · RS bench -36.7% · 1Y -55.2%0 of 12 weeks ahead 100% evidence
Exact sum: 16.9 + 10.1 + 9.4 + 1.9 = 38.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
23Pilgrim's Pride CorporationPPC 33.7/100Thin evidence · provisional56% evidence BASING 12.8/35 Revenue — · PAT — · OPM change -5.5 pp 39% evidence 8.7/25 ROCE 0.9% · OPM 3.6% 76% evidence 10.2/20 P/E 12.5× · PEG — 15% evidence 2.0/20 RS sector -29.2% · RS bench -34.5% · 1Y -46%0 of 12 weeks ahead 100% evidence
Exact sum: 12.8 + 8.7 + 10.2 + 2 = 33.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
24J&J Snack Foods Corp.JJSF 33.4/100Thin evidence · provisional60% evidence BASING 14.6/35 Revenue -2.1% · PAT -23.7% · OPM change -1.2 pp 53% evidence 9.0/25 ROCE 0.2% · OPM 0.5% 57% evidence 3.8/20 P/E 26.8× · PEG 6.43 65% evidence 6.0/20 RS sector -13.2% · RS bench -19.5% · 1Y -28.1%0 of 12 weeks ahead 70% evidence
Exact sum: 14.6 + 9 + 3.8 + 6 = 33.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
25General Mills, Inc.GIS 27.7/100Adverse evidence71% evidence BASING 5.8/35 Revenue -5.4% · PAT -103.7% · OPM change -56.5 pp 83% evidence 6.5/25 ROCE -8.6% · OPM -45.4% 76% evidence 10.7/20 P/E 10.9× · PEG — 15% evidence 4.7/20 RS sector -17.9% · RS bench -24% · 1Y -27.4%0 of 12 weeks ahead 100% evidence
Exact sum: 5.8 + 6.5 + 10.7 + 4.7 = 27.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26The Simply Good Foods CompanySMPL 23.6/100Adverse evidence65% evidence ASLEEP 5.4/35 Revenue -4.5% · PAT -237.2% · OPM change -29.6 pp 83% evidence 5.7/25 ROCE -2.3% · OPM -14% 76% evidence 9.2/20 P/E 21.9× · PEG — 15% evidence 3.3/20 RS sector -38.1% · RS bench -43.3% · 1Y -61.5%1 of 12 weeks ahead 70% evidence
Exact sum: 5.4 + 5.7 + 9.2 + 3.3 = 23.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Westrock Coffee CompanyWEST 52.8/100Thin evidence · provisional48% evidence ASLEEP 21.7/35 Revenue 47.3% · PAT — · OPM change 7.1 pp 40% evidence 7.1/25 ROCE 0.4% · OPM 1% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 14.0/20 RS sector 34.5% · RS bench 27.8% · 1Y 14.2%11 of 12 weeks ahead 100% evidence
Exact sum: 21.7 + 7.1 + 10 + 14 = 52.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
28Herbalife Ltd.HLF 51.3/100Thin evidence · provisional50% evidence ASLEEP 17.6/35 Revenue 3.7% · PAT -15% · OPM change 0.4 pp 53% evidence 14.8/25 ROCE 8.1% · OPM 10.5% 57% evidence 11.5/20 P/E 6.5× · PEG — 15% evidence 7.4/20 RS sector -4.9% · RS bench -10.8% · 1Y 43.8%0 of 12 weeks ahead 70% evidence
Exact sum: 17.6 + 14.8 + 11.5 + 7.4 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Once Upon A Farm, PBCOFRM 45.1/100Thin evidence · provisional28% evidence FADING 19.6/35 Revenue 48.6% · PAT — · OPM change -4 pp 40% evidence 5.5/25 ROCE -15.8% · OPM -22.2% 57% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —4 of 12 weeks ahead 0% evidence
Exact sum: 19.6 + 5.5 + 10 + 10 = 45.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30The Magnum Ice Cream Company N.V.MICC 44.6/100Thin evidence · provisional18% evidence BREAKING OUT 16.7/35 Revenue — · PAT — · OPM change — 9% evidence 9.2/25 ROCE 0.4% · OPM — 46% evidence 8.7/20 P/E 28.1× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence
Exact sum: 16.7 + 9.2 + 8.7 + 10 = 44.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Smithfield Foods, Inc.'s stock price today?

Smithfield Foods, Inc. trades at $25.3, +4.2% over the past year. The company is valued at $10.0 B. The stock sits at 51% of its 52-week range of $21–$29, +3.4% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 9 weeks in. — as of 5 August 2026.

What were Smithfield Foods, Inc.'s latest quarterly results?

Smithfield Foods, Inc. reported revenue of $3.8 B and net profit of $0.3 B for the Mar 26 quarter. Revenue rose 0.8% and profit rose 8.7% year on year. Earnings per share were $0.62. The operating margin was 8.7%, 0.2 pp higher than a year earlier. — as of 5 August 2026.

What is Smithfield Foods, Inc.'s revenue?

Smithfield Foods, Inc. reported revenue of $3.8 B in the Mar 26 quarter, +0.8% year on year. For the full FY25 fiscal year, revenue was $15.5 B (+9.8%). Over the last 12 years revenue compounded at 1.4% a year. — as of 5 August 2026.

What is Smithfield Foods, Inc.'s profit?

Smithfield Foods, Inc. earned $0.3 B of net profit in the Mar 26 quarter, +8.7% year on year — the 3rd straight quarter of growth. Full-year FY25 profit was $1.0 B. The operating margin ran 8.7% in the latest quarter. — as of 5 August 2026.

What is Smithfield Foods, Inc.'s market cap?

Smithfield Foods, Inc.'s market capitalisation is $10.0 B at a stock price of $25.3. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

What is Smithfield Foods, Inc.'s P/E ratio?

Smithfield Foods, Inc. trades at a P/E of 9.9×, at the 56th percentile of its own 2-year range, against a long-run median of 9.8×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.

Does Smithfield Foods, Inc. pay a dividend?

Yes — Smithfield Foods, Inc. declared $0.31 per share for Mar 26, and $1.06 per share across the last four reported quarters. The latest quarter is up 25.0% on the same quarter a year earlier. — as of 5 August 2026.

What is Smithfield Foods, Inc.'s dividend per share?

Smithfield Foods, Inc.'s most recently declared dividend is $0.31 per share for Mar 26, giving $1.06 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.

What is Smithfield Foods, Inc.'s dividend yield?

Smithfield Foods, Inc.'s trailing dividend yield is 4.18%: $1.06 declared per share across the last four reported quarters, against a share price of $25.3. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.

Is Smithfield Foods, Inc. overvalued?

On its own history, Smithfield Foods, Inc. looks mid-range against its own history: its P/E of 9.9× sits at the 56th percentile of its 2-year range (long-run median 9.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.

Is Smithfield Foods, Inc. growing?

Yes — Smithfield Foods, Inc. is growing: latest-quarter revenue +0.8% year on year, profit +8.7%, and the margin +0.2 pp at 8.7%. The 12-year compound rates are 1.4% (revenue) and 15.4% (profit). The earnings engine currently reads: improving — as of 5 August 2026.

How is Smithfield Foods, Inc. performing?

Smithfield Foods, Inc. is in a confirmed uptrend, 9 weeks in. Its latest quarter's revenue rose 0.8% and profit rose 8.7% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 8 weeks. This describes what the data did, not a rating. — as of 5 August 2026.

What stage is Smithfield Foods, Inc. in?

Mixed — no clean majority across the growth curves, ROCE holding at 12.9% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +7.7% latest, profit growth +10.9% latest, eps growth −4.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.

Is Smithfield Foods, Inc. in an uptrend?

Yes — the price is in a confirmed uptrend (week 9 of stage 2), trading +3.4% versus its 200-day average and at 51% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.

Is Smithfield Foods, Inc. beating the market?

Not lately — on a trailing-13-week view Smithfield Foods, Inc. is currently behind the S&P 500 (8 weeks and counting; last ahead the week of 2026-06-12), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.5 years the stock moved +18% against the S&P 500's +28% — behind the index over the full window. — as of 5 August 2026.

Will Smithfield Foods, Inc.'s stock price go up?

This page publishes no price forecast for Smithfield Foods, Inc. What it measures instead: the stock price is $25.3, the price is in a confirmed uptrend 9 weeks in. Its P/E of 9.9× sits at the 56th percentile of its own 2-year range. — as of 5 August 2026.

Is the market betting against Smithfield Foods, Inc.?

Yes — short interest is 12.6% of Smithfield Foods, Inc.'s tradable float, about 4.1 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

Does Smithfield Foods, Inc. have too much debt?

It is moderate — Smithfield Foods, Inc.'s debt-to-equity is 0.33. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.

What is Smithfield Foods, Inc.'s capex?

Smithfield Foods, Inc. spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.3 B. — as of 5 August 2026.

What is Smithfield Foods, Inc.'s cash flow?

Smithfield Foods, Inc. generated $1.1 B of operating cash flow in FY25 and $0.7 B of free cash flow after $0.3 B of capital spending. Reported profit that year was $1.0 B, so operating cash ran ahead of profit. — as of 5 August 2026.

Is Smithfield Foods, Inc.'s profit real cash?

Yes — over the last 3 fiscal years, 109% of Smithfield Foods, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $1.1 B against reported profit of $1.0 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.

How financially safe is Smithfield Foods, Inc.?

On the balance sheet, the Z-score reads 3.55 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.

Where is Smithfield Foods, Inc. in its business cycle?

Smithfield Foods, Inc.'s FY25 operating margin was 8.3%, against a 5-year band of 2.4%–8.3%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 8.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the Smithfield Foods, Inc. story?

Biggest watch item: margins are the best this company has ever printed — every ratio flatters at record profitability, so the whole story leans on margins holding. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is Smithfield Foods, Inc. a stock worth studying right now?

This is not investment advice. The machine read: Smithfield Foods, Inc. is printing record margins on a fuller multiple. From here the earnings must do all the lifting. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI